Bruker Corp (BRKR) concluded trading on Wednesday at a closing price of $40.93, with 4.66 million shares of worth about $190.61 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -25.97% during that period and on June 25, 2025 the price saw a gain of about 3.20%. Currently the company’s common shares owned by public are about 151.52M shares, out of which, 102.99M shares are available for trading.
Stock saw a price change of 8.80% in past 5 days and over the past one month there was a price change of 15.30%. Year-to-date (YTD), BRKR shares are showing a performance of -38.00% which decreased to -30.18% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $34.10 but also hit the highest price of $72.94 during that period. The average intraday trading volume for Bruker Corp shares is 2.38 million. The stock is currently trading 6.43% above its 20-day simple moving average (SMA20), while that difference is up 6.57% for SMA50 and it goes to -20.56% lower than SMA200.
Bruker Corp (NASDAQ: BRKR) currently have 151.52M outstanding shares and institutions hold larger chunk of about 81.01% of that.
The stock has a current market capitalization of $6.20B and its 3Y-monthly beta is at 1.17. PE ratio of stock for trailing 12 months is 77.95, while it has posted earnings per share of $0.53 in the same period. Its PEG reads 8.25 and has Quick Ratio of 0.74 while making debt-to-equity ratio of 1.16. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BRKR, volatility over the week remained 1.76% while standing at 2.16% over the month.
Stock’s fiscal year EPS is expected to rise by 0.88% while it is estimated to increase by 12.59% in next year. EPS is likely to grow at an annualized rate of 9.45% for next 5-years, compared to annual growth of -9.69% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on May 22, 2025 offering a Neutral rating for the stock and assigned a target price of $40 to it. Coverage by Guggenheim stated Bruker Corp (BRKR) stock as a Buy in their note to investors on December 19, 2024, suggesting a price target of $72 for the stock. On December 10, 2024, UBS Initiated their recommendations, while on December 05, 2024, Goldman Upgrade their ratings for the stock with a price target of $60. Stock get an Overweight rating from Barclays on October 15, 2024.
